Serum B cell–activating factor (BAFF) level in connective tissue disease associated interstitial lung disease

[1] Fischer A(2012)Interstitial lung disease in connective tissue disorders Lancet 380 689-698

[2] du Bois R(2013)Diagnosis and treatment of connective tissue disease-associated interstitial lung disease Chest 143 814-824

[3] Vij R(2011)Does the presence of connective tissue disease modify survival in patients with pulmonary fibrosis? Respir Med. 105 1925-30

[4] Strek ME(2013)Mycophenolate mofetil improves lung function in connective tissue disease-associated interstitial lung disease J Rheumatol 40 640-646

[5] Navaratnam V(2006)Cyclophosphamide versus placebo in scleroderma lung disease N Engl J Med 354 2655-2666

[6] Ali N(2013)An official american thoracic society/european respiratory society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias Am J Respir Crit Care Med 188 733-748

[7] Smith CJP(2007)Idiopathic nonspecific interstitial pneumonia: lung manifestation of undifferentiated connective tissue disease? Am J Respir Crit Care Med 176 691-697

[8] McKeever T(2011)Autoimmune-featured interstitial lung disease: a distinct entity Chest 140 1292-1299

[9] Fogarty A(1999)BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator Science 285 260-263

[10] Hubbard RB(1999)BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth J Exp Med 189 1747-1756

[1] Fischer A(2012)Interstitial lung disease in connective tissue disorders Lancet 380 689-698

[2] du Bois R(2013)Diagnosis and treatment of connective tissue disease-associated interstitial lung disease Chest 143 814-824

[3] Vij R(2011)Does the presence of connective tissue disease modify survival in patients with pulmonary fibrosis? Respir Med. 105 1925-30

[4] Strek ME(2013)Mycophenolate mofetil improves lung function in connective tissue disease-associated interstitial lung disease J Rheumatol 40 640-646

[5] Navaratnam V(2006)Cyclophosphamide versus placebo in scleroderma lung disease N Engl J Med 354 2655-2666

[6] Ali N(2013)An official american thoracic society/european respiratory society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias Am J Respir Crit Care Med 188 733-748

[7] Smith CJP(2007)Idiopathic nonspecific interstitial pneumonia: lung manifestation of undifferentiated connective tissue disease? Am J Respir Crit Care Med 176 691-697

[8] McKeever T(2011)Autoimmune-featured interstitial lung disease: a distinct entity Chest 140 1292-1299

[9] Fogarty A(1999)BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator Science 285 260-263

[10] Hubbard RB(1999)BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth J Exp Med 189 1747-1756